Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HALO
Stock Latest News
The Fly
Leerink views ‘major deal’ on Entyvio as positive for Halozyme
7d ago
TAK
HALO
Premium
Ratings
Halozyme: ENHANZE Platform Partnerships in Immunology and Obesity Drive Underappreciated Royalty Upside and Support Buy Rating
7d ago
HALO
Premium
The Fly
Halozyme price target raised to $90 from $79 at TD Cowen
7d ago
HALO
Premium
The Fly
Halozyme announces global collaboration, license agreement with Takeda
7d ago
TAK
HALO
Premium
The Fly
Halozyme price target lowered to $75 from $79 at Morgan Stanley
7d ago
HALO
Premium
The Fly
CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
9d ago
ACN
CVX
Premium
The Fly
Skye Bioscience, Halozyme enter collaboration, license agreement
10d ago
HALO
SKYE
Premium
The Fly
Halozyme, Skye Bioscience announce global collaboration, license agreement
10d ago
HALO
SKYE
Premium
Ratings
Rybrevant FASPRO Approval and ENHANZE Royalties Reset Halozyme’s Long-Term Growth Outlook, Supporting a Buy Rating and $90 Target
27d ago
HALO
Premium
The Fly
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
28d ago
JNJ
HALO
Premium
Company Announcements
Halozyme Approves Stock Grant for CEO Incentive
1M ago
8K
HALO
Premium
Company Announcements
Halozyme Elects James Lang to Board of Directors
1M ago
8K
HALO
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
1M ago
DG
PD
Premium
The Fly
Halozyme wins preliminary injunction against Merck’s Keytruda SC in Germany
1M ago
MRK
HALO
Premium
The Fly
Toast upgraded, PayPal downgraded: Wall Street’s top analyst calls
1M ago
GE
AAL
Premium
The Fly
Halozyme downgraded to Sell from Neutral at Goldman Sachs
1M ago
HALO
Premium
Ratings
Strategic Acquisition and FDA Approval Bolster Halozyme’s Market Position with a Buy Rating
2M ago
HALO
Premium
Company Announcements
Halozyme Announces CFO Transition Plan
2M ago
8K
HALO
Premium
Ratings
Strategic Importance of Halozyme’s ENHANZE Platform and Its Growth Potential in Subcutaneous Drug Delivery
2M ago
HALO
Premium
The Fly
Halozyme price target raised to $56 from $54 at Goldman Sachs
2M ago
HALO
Premium
The Fly
Merus, Halozyme enter collaboration, license agreement for petosemtamab
2M ago
HALO
MRUS
Premium
Company Announcements
Halozyme Completes $1.5 Billion Convertible Notes Sale
2M ago
8K
HALO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.